Similarly, expression of Cide-A, a cell death activator protein A, which is a lipid droplet-specific binding protein, was upregulated in myelolipoma and not in both CAH and control adrenals (p < 0.001) (Figure 3B). The gene discussed is CIDEA; the disease is adrenal gland myelolipoma.